As an AAHRPP-accredited, unbiased, non-profit IRB, Salus IRB is committed to upholding the highest standards in human research protection while providing the same high level of service and expertise that our customers have relied on for more than 35 years.
Salus IRB employs a consultative partnership approach when working with sponsors and investigators, providing added value by delivering IRB services in a convenient, reliable and efficient manner.
Salus announces NEW IRBManager Submission System
Effective Monday, January 15, SalusIRB conducts protocol reviews with the online research management system: IRBManager.
Current clients with active studies approved by SalusIRB logging in for the first time should enter their email address and select ‘Forgot Password’. An email will be sent with instructions for setting up their personal password.
Clients who do not have an active study or for whom the system did not recognize the provided email, please select ‘Click here to register’ to set up your account.
While existing form-fillable documents will be accepted through January 31st, we encourage all clients to begin using IRBManager. Existing clients received instructional account setup and access information via email. For additional FAQs contact clientservices@SalusIRB.com to reach one of our team members or request a web-based training session for your research team.
Dedicated client service managers
Streamlined document submission and delivery process
Industry-leading review and response times
IRB meetings held every Monday, Tuesday, Wednesday and Friday
Same-day expedited review
Comprehensive review services for phase I-IV research
Experience in toxicology and accelerated phase I review services
Dedicated oncology board with experience reviewing oncology research, including phase I
Single IRB / Central IRB services for multi-site trials
IRB Review Boards
Expert physicians, pharmacists, attorneys and toxicologists.
Minimal Risk / IRB Exempt Services
Single-site, multi-site and international review services for clinical trials.
Research Review Services
Salus IRB board members include expert physicians, pharmacists, attorneys, toxicologists and more. They review phase I-IV clinical trials, as well as post-marketing research, in a variety of therapeutic areas.
Cenetron
Cenetron is an industry-leading central laboratory service provider for the facilitation of unique pharmaceutical clinical trials.
Versiti
Versiti has more than 75 years of experience in blood health innovation, including research, diagnostic testing and clinical trials.